WallStreetZenWallStreetZen

NASDAQ: DCOY
Decoy Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DCOY

Based on 1 analyst offering 12 month price targets for Decoy Therapeutics Inc

Min Forecast
$2.50+224.25%
Avg Forecast
$2.50+224.25%
Max Forecast
$2.50+224.25%

Should I buy or sell DCOY stock?

Based on 1 analyst offering ratings for Decoy Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DCOY's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates DCOY as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their DCOY stock forecasts and price targets.

DCOY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-23

1 of 1

Forecast return on equity

Is DCOY forecast to generate an efficient return?

Forecast return on assets

Is DCOY forecast to generate an efficient return on assets?

DCOY revenue forecast

What is DCOY's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$12.1M

DCOY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DCOY$0.77$2.50+224.25%Strong Buy
SILO$0.35N/AN/A
SXTP$4.15$17.60+324.10%Buy
GRI$3.26$1,008.00+30,820.25%Buy
MLEC$6.50N/AN/A
View Top Biotech Stocks

Decoy Therapeutics Stock Forecast FAQ

Is Decoy Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DCOY) stock is to Strong Buy DCOY stock.

Out of 1 analyst, 1 (100%) are recommending DCOY as a Strong Buy, 0 (0%) are recommending DCOY as a Buy, 0 (0%) are recommending DCOY as a Hold, 0 (0%) are recommending DCOY as a Sell, and 0 (0%) are recommending DCOY as a Strong Sell.

If you're new to stock investing, here's how to buy Decoy Therapeutics stock.

What is DCOY's revenue growth forecast for 2026-2026?

(NASDAQ: DCOY) Decoy Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Decoy Therapeutics's revenue in 2026 is $0.

In 2026, DCOY is forecast to generate $71,008,562 in revenue, with the lowest revenue forecast at $68,224,028 and the highest revenue forecast at $73,095,497.

What is DCOY's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: DCOY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 18.25%.

What is DCOY's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DCOY price target, the average DCOY price target is $2.50, with the highest DCOY stock price forecast at $2.50 and the lowest DCOY stock price forecast at $2.50.

The Wall Street analyst predicted that Decoy Therapeutics's share price could reach $2.50 by Jan 23, 2027. The average Decoy Therapeutics stock price prediction forecasts a potential upside of 224.25% from the current DCOY share price of $0.77.

What is DCOY's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: DCOY) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.